Evaluation of melatonin effects on oxidative stress in hemodialysied patiant
Phase 2
- Conditions
- Chronic renal patients undergoing hemodialysis.Encounter for care involving renal dialysis
- Registration Number
- IRCT20190120042430N1
- Lead Sponsor
- Oroumia University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 32
Inclusion Criteria
Patients should be at least two months before the start of the study are under dialysis
Patients should not have smoking
Principles of dialysis and dialysis person, long-term drug therapy during the study needs to be fixed.
Exclusion Criteria
The patient during the study to undergo the surgery
pregnancy or breast-feeding during the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum Glutathione. Timepoint: At the first of the study,30 and 60 days after start of melatonin. Method of measurement: eastbiopharm Lab kit.
- Secondary Outcome Measures
Name Time Method Superoxiddismutase. Timepoint: At the first of study, 30 and 60 dayse after start of melatonin. Method of measurement: Nasdox Lab kit of navande salamat.